Since MYC amp is a significant negative prognostic factor in other malignancies, and there is a suggestion that low-level MYC copy number changes may play a similar role in BCLs, we hypothesized that high-level MYC amp (defined as above) would have a negative effect on outcomes in DLBCL. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.